Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions.
Value Health. 2017.
PMID: 28237201
Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 2017 | 1 |
| 2020 | 1 |
| 2023 | 1 |
Search Results
3 results
Results by year
Citations
1
article
found by citation matching
Search results
Filters applied: . Clear all
Page 1
Developing a Value Framework: The Need to Reflect the Opportunity Costs of Funding Decisions.
Sculpher M, Claxton K, Pearson SD.
Sculpher M, et al.
Value Health. 2017 Feb;20(2):234-239. doi: 10.1016/j.jval.2016.11.021.
Value Health. 2017.
PMID: 28237201
Free article.
A key principle that is invariably neglected in current and proposed frameworks is the need to reflect evidence on the opportunity costs that health systems face when making funding decisions. ...These opportunity costs …
A key principle that is invariably neglected in current and proposed frameworks is the need to reflect evidence on the …
Item in Clipboard
Reflecting the Health Opportunity Costs of Funding Decisions Within Value Frameworks: Initial Estimates and the Need for Further Research.
Ochalek J, Lomas J.
Ochalek J, et al.
Clin Ther. 2020 Jan;42(1):44-59.e2. doi: 10.1016/j.clinthera.2019.12.002. Epub 2020 Jan 16.
Clin Ther. 2020.
PMID: 31955967
PURPOSE: Evaluating whether a new health technology provides good value for money requires an assessment of its opportunity cost. If the opportunity cost of the new health technology exceeds the benefits, however measured, a net loss is produced …
PURPOSE: Evaluating whether a new health technology provides good value for money requires an assessment of its opportunity …
Item in Clipboard
Access to novel drugs and therapeutics for children and youth: Eliciting citizens' values to inform public funding decisions.
Gauvreau CL, Wight L, Subasri M, Palmer A, Hayeems R, Croker A, Abelson J, Fraser B, Bombard Y, Moore Hepburn C, Wilson MG, Denburg A.
Gauvreau CL, et al.
Health Expect. 2023 Apr;26(2):715-727. doi: 10.1111/hex.13697. Epub 2023 Jan 14.
Health Expect. 2023.
PMID: 36639959
Free PMC article.
INTRODUCTION: The unique evidentiary, economic and ethical challenges associated with health technology assessment (HTA) of precision therapies limit access to novel drugs and therapeutics for children and youth, for whom such challenges are amplified. We elicited citizens' persp …
INTRODUCTION: The unique evidentiary, economic and ethical challenges associated with health technology assessment (HTA) of precision therap …
Item in Clipboard
Cite
Cite